AI assistant
Sending…
CYCLOPHARM LIMITED — Director's Dealing 2007
Feb 11, 2007
64741_rns_2007-02-11_23f0651f-97ab-4abc-9a5d-0631b52bd57d.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Rule 3.19A.1
Appendix 3X
Initial Director's Interest Notice
| Name of entity CYCLOPHARM LIMITED | |
|---|---|
| ABN | 74 116 931 250 |
We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | John Stuart Sharman |
|---|---|
| Date of appointment | 22/11/2005 |
Part 1 - Director's relevant interests in securities of which the director is the registered holder
| Number & class of securities Ordinary Shares |
2,484,755 |
|---|---|
| Direct: | 2,484,755 |
$\overline{\text{+ See chapter 19}}$ for defined terms.
Part 2 – Director's relevant interests in securities of which the director is not the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
| Name of holder & nature of interest | Number & class of Securities | |
|---|---|---|
| • CVC Venture Managers Pty Ltd | Ordinary Shares | 208,749 |
| • JAAJ's Investments Pty Ltd | Ordinary Shares | 34,977 |
| Indirect: | 243,726 | |
| Total (Direct & Indirect): | 2,728,481 |
Part 3 – Director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
| Detail of contract | Nil |
|---|---|
| Nature of interest | |
| Name of registered holder (if issued securities) |
|
| No. and class of securities to which interest relates |
$\overline{\text{+ See chapter 19}}$ for defined terms.
More from CYCLOPHARM LIMITED
Director's Dealing
2026
May 7
Director's Dealing
2026
May 7
Declaration of Voting Results & Voting Rights Announcements
2026
May 7
AGM Information
2026
May 7
AGM Information
2026
May 7
AGM Information
2026
May 7
Board/Management Information
2026
May 3
Director's Dealing
2026
May 3
Major Shareholding Notification
2026
Apr 21
Capital/Financing Update
2026
Apr 19